EasyManua.ls Logo

Quidel Triage MeterPro - Quality Assurance Functions; Internal Device Quality Assurance

Quidel Triage MeterPro
86 pages
Print Icon
To Next Page IconTo Next Page
To Next Page IconTo Next Page
To Previous Page IconTo Previous Page
To Previous Page IconTo Previous Page
Loading...
Page72of86
additionalreagents.Eachdevicecontainsafullcompleme ntof reagentsthatarerequiredtoperformthe
immunoassay.
TheQuidelTriagetestshavebeendesignedtoincludeassaycontrolsineachtestdevicethatmonitorthe
assayprocedureandthereagentintegrity.Theassaycontrolspresentauniqueandvaluableextensionto
thetraditionalapproachtoqualitycontrolusingliquidreagents.Iftheproductisstoredunderspecifie d
conditions,
properfunctioningoftheassaycontrolsindicatesthatthetestdeviceisvalidandproper
adherencetoassayprotocolhasbeenfollowed.TheassaycontrolsintheQuidelTriagetestsrequirethe
needtoreͲthinkthefrequencywithwhichexternalqualitycontrolspecimensshouldbetested.
TheQuidelTriage
testshavebeendesignedtoyieldlong Ͳtermreagentstability.Inaddition, thesystem
providesqualitycontrolparametersinthreeseparateanddistinctcategories:
Internaldevicecontrols
Meterelectroniccontrols
Softwarecontrols.
Thecombinationofthesequalitycontrolfeaturesprovides moreinformationaboutthevalidityofeach
assaythancanbeprovidedbythemoretraditionalmethodsofreagentandassayprocedurevalidation.
QualityAssuranceFunctions
1. InternalDeviceQualityAssurance
InternalPositiveControlZone
BaselineControlZone
TimingControlZone
ZoneQualityRequirements(TraceQC)
2. MeterQualityAssurance
SelfͲTestMode
InternalCalibrationChip
ElectronicQCDevice
BarCode
3. SoftwareQualityAssurance
SupervisorCODECHIP
module
UserID#
PatientID#
Resultmemorystorage
QCFrequency
QCLockouts
4. QualityControlSamples
InternalDeviceQualityAssurance
TheInternalControlZonesarebuiltͲin functionalimmunoassays.Thiscontrolverifiesthatthedevice
functionedproperlyandthattheassaywascorrectlyperformed.TheInternalPositiveControlZoneensures
thattheantibodies,thereagentreconstitution,thetimegateandthedeviceflowarefunctioning properly.
Themanufacturersetsacceptablerangesfor
thecontrolzonesforeachlotofreagents.
TheBaselineControlZonemonitorsthepresenceofinterferingsubstancesinthepatientsamplethat may
altertheimmunoassayprocess.Ifaspecimencontainsasubstancethathasamajoreffectonthehighand

Table of Contents